Skip to content
Home/Companies/Biotech/Cardior Pharmaceuticals
CP

Cardior Pharmaceuticals

Biotech·Germany·Exited 2024·Held 3yr

Cardior Pharmaceuticals is a biotech company, headquartered in Germany.

Entry
2021
Hold
3yr
Exit
2024
Est. EV
–

Who owns Cardior Pharmaceuticals?

Cardior Pharmaceuticals was owned by coparion through coparion (2016 vintage) from 2021 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

coparion
Investor
coparion
coparion · 2016 · VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from coparion

Other portfolio companies in the same fund.

Lanes & Planes
Active
SaaSGermany· 2023
CNC24
Active
SoftwareGermany· 2022
ContractHero
Active
SaaSGermany· 2021
PlanA.Earth
Active
ClimateTechGermany· 2021
3YOURMIND
Active
SoftwareGermany· 2020
CatalYm
Active
BiotechGermany· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings